Advertisement
Screener

Elanco Animal Health Incorporated (ELAN) Proceeds from (Payments for) Other Financing Activities

2.8 / 5 stars · 68/120 Roast Me

Elanco Animal Health Incorporated Proceeds from (Payments for) Other Financing Activities

Elanco Animal Health Incorporated (ELAN) reported Proceeds from (Payments for) Other Financing Activities of -$15.00 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.

Financial Statements › Cash Flow › Financing Activities

us-gaap:ProceedsFromPaymentsForOtherFinancingActivities · last filed 2026-08-05

  • Elanco Animal Health Incorporated proceeds from (payments for) other financing activities for the quarter ending 2026-06-30 was $0.00, a 100.00% decline year-over-year.
  • Elanco Animal Health Incorporated proceeds from (payments for) other financing activities for the quarter ending 2026-03-31 was -$15.00M.
  • Elanco Animal Health Incorporated proceeds from (payments for) other financing activities for the quarter ending 2025-12-31 was -$17.00M, a 383.33% decline year-over-year.
  • Elanco Animal Health Incorporated proceeds from (payments for) other financing activities for the quarter ending 2025-09-30 was $21.00M.
  • Elanco Animal Health Incorporated proceeds from (payments for) other financing activities for fiscal 2025 was -$2.00M.
  • Elanco Animal Health Incorporated proceeds from (payments for) other financing activities for fiscal 2024 was -$17.00M.
  • Elanco Animal Health Incorporated proceeds from (payments for) other financing activities for fiscal 2023 was -$6.00M.
  • Elanco Animal Health Incorporated proceeds from (payments for) other financing activities for fiscal 2022 was -$32.00M.
Period endProceeds from (Payments for) Other Financing Activities 3 monthProceeds from (Payments for) Other Financing Activities 3 month as first filedProceeds from (Payments for) Other Financing Activities 6 monthProceeds from (Payments for) Other Financing Activities 6 month as first filedProceeds from (Payments for) Other Financing Activities 9 monthProceeds from (Payments for) Other Financing Activities 9 month as first filedProceeds from (Payments for) Other Financing Activities 12 monthProceeds from (Payments for) Other Financing Activities 12 month as first filed
2026-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05
-$15.00M
10-Q · filed 2026-08-05
-$32.00M
derived: sum of 3 quarters · filed 2026-08-05
-$11.00M
derived: sum of 4 quarters · filed 2026-08-05
2026-03-31-$15.00M
10-Q · filed 2026-05-06
-$32.00M
derived: sum of 2 quarters · filed 2026-05-06
-$11.00M
derived: sum of 3 quarters · filed 2026-05-06
-$10.00M
derived: sum of 4 quarters · filed 2026-08-05
2025-12-31-$17.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24
$4.00M
derived: sum of 2 quarters · filed 2026-02-24
$5.00M
derived: sum of 3 quarters · filed 2026-08-05
-$2.00M
10-K · filed 2026-02-24
2025-09-30$21.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05
$22.00M
derived: sum of 2 quarters · filed 2026-08-05
$15.00M
10-Q · filed 2025-11-05
$21.00M
derived: sum of 4 quarters · filed 2026-08-05
2025-06-30$1.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05
-$6.00M
10-Q · filed 2026-08-05
-$20.00M
10-Q · filed 2025-08-07
$0.00
derived: sum of 3 quarters · filed 2026-08-05
-$8.00M
derived: sum of 4 quarters · filed 2026-08-05
2025-03-31-$7.00M
10-Q · filed 2026-05-06
-$20.00M
10-Q · filed 2025-05-07
-$1.00M
derived: sum of 2 quarters · filed 2026-05-06
-$9.00M
derived: sum of 3 quarters · filed 2026-05-06
-$10.00M
derived: sum of 4 quarters · filed 2026-05-06
2024-12-31$6.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24
-$2.00M
derived: sum of 2 quarters · filed 2026-02-24
-$3.00M
derived: sum of 3 quarters · filed 2026-02-24
-$17.00M
10-K · filed 2026-02-24
2024-09-30-$8.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05
-$9.00M
derived: sum of 2 quarters · filed 2025-11-05
-$23.00M
10-Q · filed 2025-11-05
-$23.00M
derived: sum of 4 quarters · filed 2026-02-24
2024-06-30-$1.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07
-$15.00M
10-Q · filed 2025-08-07
-$15.00M
derived: sum of 3 quarters · filed 2026-02-24
-$16.00M
derived: sum of 4 quarters · filed 2026-02-24
2024-03-31-$14.00M
10-Q · filed 2025-05-07
-$14.00M
derived: sum of 2 quarters · filed 2026-02-24
-$15.00M
derived: sum of 3 quarters · filed 2026-02-24
-$13.00M
derived: sum of 4 quarters · filed 2026-02-24
2023-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24
-$1.00M
derived: sum of 2 quarters · filed 2026-02-24
$1.00M
derived: sum of 3 quarters · filed 2026-02-24
-$6.00M
10-K · filed 2026-02-24
2023-09-30-$1.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07
$1.00M
derived: sum of 2 quarters · filed 2024-11-07
-$6.00M
10-Q · filed 2024-11-07
-$5.00M
derived: sum of 4 quarters · filed 2025-02-25
2023-06-30$2.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08
-$5.00M
10-Q · filed 2024-08-08
-$4.00M
derived: sum of 3 quarters · filed 2025-02-25
-$20.00M
derived: sum of 4 quarters · filed 2025-02-25
2023-03-31-$7.00M
10-Q · filed 2024-05-08
-$6.00M
derived: sum of 2 quarters · filed 2025-02-25
-$22.00M
derived: sum of 3 quarters · filed 2025-02-25
-$28.00M
derived: sum of 4 quarters · filed 2025-02-25
2022-12-31$1.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25
-$15.00M
derived: sum of 2 quarters · filed 2025-02-25
-$21.00M
derived: sum of 3 quarters · filed 2025-02-25
-$32.00M
10-K · filed 2025-02-25
-$16.00M
10-K · filed 2023-03-01
2022-09-30-$16.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07
-$22.00M
derived: sum of 2 quarters · filed 2023-11-07
-$33.00M
10-Q · filed 2023-11-07
-$17.00M
10-Q · filed 2022-11-08
-$47.00M
derived: sum of 4 quarters · filed 2024-02-26
2022-06-30-$6.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-07
-$17.00M
10-Q · filed 2023-08-07
-$31.00M
derived: sum of 3 quarters · filed 2024-02-26
-$31.00M
derived: sum of 4 quarters · filed 2024-02-26
2022-03-31-$11.00M
10-Q · filed 2023-05-09
-$25.00M
derived: sum of 2 quarters · filed 2024-02-26
-$25.00M
derived: sum of 3 quarters · filed 2024-02-26
-$25.00M
derived: sum of 4 quarters · filed 2024-02-26
2021-12-31-$14.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-26
-$14.00M
derived: sum of 2 quarters · filed 2024-02-26
-$14.00M
derived: sum of 3 quarters · filed 2024-02-26
-$31.00M
10-K · filed 2024-02-26
-$29.00M
10-K · filed 2022-02-28
2021-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08
$0.00
derived: sum of 2 quarters · filed 2022-11-08
-$17.00M
10-Q · filed 2022-11-08
-$18.00M
derived: sum of 4 quarters · filed 2023-03-01
2021-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08
-$17.00M
10-Q · filed 2022-08-08
-$18.00M
derived: sum of 3 quarters · filed 2023-03-01
-$19.00M
derived: sum of 4 quarters · filed 2023-03-01
2021-03-31-$17.00M
10-Q · filed 2022-05-09
-$18.00M
derived: sum of 2 quarters · filed 2023-03-01
-$19.00M
derived: sum of 3 quarters · filed 2023-03-01
-$20.00M
derived: sum of 4 quarters · filed 2023-03-01
2020-12-31-$1.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01
-$2.00M
derived: sum of 2 quarters · filed 2023-03-01
-$3.00M
derived: sum of 3 quarters · filed 2023-03-01
-$16.00M
10-K · filed 2023-03-01
-$16.20M
10-K · filed 2021-03-01
2020-09-30-$1.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-05
-$2.00M
derived: sum of 2 quarters · filed 2021-11-05
-$15.00M
10-Q · filed 2021-11-05
-$15.20M
10-Q · filed 2020-11-06
-$8.70M
derived: sum of 4 quarters · filed 2022-02-28
2020-06-30-$1.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09
-$14.00M
10-Q · filed 2021-08-09
-$14.20M
10-Q · filed 2020-07-30
-$7.70M
derived: sum of 3 quarters · filed 2022-02-28
-$7.40M
derived: sum of 4 quarters · filed 2022-02-28
2020-03-31-$13.00M
10-Q · filed 2021-05-07
-$12.80M
10-Q · filed 2020-05-07
-$6.70M
derived: sum of 2 quarters · filed 2022-02-28
-$6.40M
derived: sum of 3 quarters · filed 2022-02-28
-$4.50M
derived: sum of 4 quarters · filed 2022-02-28
2019-12-31$6.30M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28
$6.60M
derived: sum of 2 quarters · filed 2022-02-28
$8.50M
derived: sum of 3 quarters · filed 2022-02-28
$8.00M
10-K · filed 2022-02-28
$1.60M
10-K · filed 2020-02-28
2019-09-30$300.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06
$2.20M
derived: sum of 2 quarters · filed 2020-11-06
$1.70M
10-Q · filed 2020-11-06
-$11.80M
derived: sum of 4 quarters · filed 2021-03-01
2019-06-30$1.90M
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-30
$1.40M
10-Q · filed 2020-07-30
-$12.10M
derived: sum of 3 quarters · filed 2021-03-01
-$14.90M
derived: sum of 4 quarters · filed 2021-03-01
2019-03-31-$500.00K
10-Q · filed 2020-05-07
-$14.00M
derived: sum of 2 quarters · filed 2021-03-01
-$16.80M
derived: sum of 3 quarters · filed 2021-03-01
-$17.30M
derived: sum of 4 quarters · filed 2021-03-01
2018-12-31-$13.50M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01
-$16.30M
derived: sum of 2 quarters · filed 2021-03-01
-$16.80M
derived: sum of 3 quarters · filed 2021-03-01
-$17.20M
10-K · filed 2021-03-01
2018-09-30-$2.80M
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08
-$3.30M
derived: sum of 2 quarters · filed 2019-11-08
-$3.70M
10-Q · filed 2019-11-08
-$4.00M
derived: sum of 4 quarters · filed 2020-02-28
2018-06-30-$500.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-13
-$900.00K
10-Q · filed 2019-08-13
-$1.20M
derived: sum of 3 quarters · filed 2020-02-28
2018-03-31-$400.00K
10-Q · filed 2019-05-14
-$700.00K
derived: sum of 2 quarters · filed 2020-02-28
2017-12-31-$300.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-28
-$800.00K
10-K · filed 2020-02-28
2017-09-30-$500.00K
10-Q · filed 2018-11-08
2016-12-31$0.00
10-K · filed 2019-02-20

Similar stocks

Stock NameCountryMarket CapPE Ratio
MADRIGAL PHARMACEUTICALS, INC. (MDGL)United States$11.859B-38.17
BIOMARIN PHARMACEUTICAL INC (BMRN)United States$11.879B151.80
Axsome Therapeutics, Inc. (AXSM)United States$10.274B-66.82
CORCEPT THERAPEUTICS INC (CORT)United States$12.804B169.10
BridgeBio Pharma, Inc. (BBIO)United States$12.947B-20.72
ARROWHEAD PHARMACEUTICALS, INC. (ARWR)United States$9.331B-42.28
Summit Therapeutics Inc. (SMMT)United States$13.071B-13.21
CYTOKINETICS INC (CYTK)United States$9.130B-11.86
Protagonist Therapeutics, Inc (PTGX)United States$8.883B95.52
TG THERAPEUTICS, INC. (TGTX)United States$8.805B19.05